Author
Listed:
- C. J. Marth
(University of California
† Present addresses: The University of Chicago Law School, 1111 East 60th Street, Chicago, Illinois 60637, USA (C.J.M.); Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121, USA (G.M.G.); Worldwide Medicinal Chemistry, Groton Laboratories, Pfizer Inc. Eastern Point Road, Groton, Connecticut 06340, USA (J.C.L.); Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California, 92121-1126, USA (T.P.L.); Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, USA (S.K.).)
- G. M. Gallego
(University of California
† Present addresses: The University of Chicago Law School, 1111 East 60th Street, Chicago, Illinois 60637, USA (C.J.M.); Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121, USA (G.M.G.); Worldwide Medicinal Chemistry, Groton Laboratories, Pfizer Inc. Eastern Point Road, Groton, Connecticut 06340, USA (J.C.L.); Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California, 92121-1126, USA (T.P.L.); Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, USA (S.K.).)
- J. C. Lee
(University of California
† Present addresses: The University of Chicago Law School, 1111 East 60th Street, Chicago, Illinois 60637, USA (C.J.M.); Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121, USA (G.M.G.); Worldwide Medicinal Chemistry, Groton Laboratories, Pfizer Inc. Eastern Point Road, Groton, Connecticut 06340, USA (J.C.L.); Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California, 92121-1126, USA (T.P.L.); Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, USA (S.K.).)
- T. P. Lebold
(University of California
† Present addresses: The University of Chicago Law School, 1111 East 60th Street, Chicago, Illinois 60637, USA (C.J.M.); Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121, USA (G.M.G.); Worldwide Medicinal Chemistry, Groton Laboratories, Pfizer Inc. Eastern Point Road, Groton, Connecticut 06340, USA (J.C.L.); Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California, 92121-1126, USA (T.P.L.); Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, USA (S.K.).)
- S. Kulyk
(University of California
† Present addresses: The University of Chicago Law School, 1111 East 60th Street, Chicago, Illinois 60637, USA (C.J.M.); Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121, USA (G.M.G.); Worldwide Medicinal Chemistry, Groton Laboratories, Pfizer Inc. Eastern Point Road, Groton, Connecticut 06340, USA (J.C.L.); Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California, 92121-1126, USA (T.P.L.); Theravance Biopharma US Inc., 901 Gateway Boulevard, South San Francisco, California 94080, USA (S.K.).)
- K. G. M. Kou
(University of California)
- J. Qin
(Cadre Research Labs)
- R. Lilien
(Cadre Research Labs)
- R. Sarpong
(University of California)
Abstract
General strategies for the chemical synthesis of organic compounds, especially of architecturally complex natural products, are not easily identified. Here we present a method to establish a strategy for such syntheses, which uses network analysis. This approach has led to the identification of a versatile synthetic intermediate that facilitated syntheses of the diterpenoid alkaloids weisaconitine D and liljestrandinine, and the core of gomandonine. We also developed a web-based graphing program that allows network analysis to be easily performed on molecules with complex frameworks. The diterpenoid alkaloids comprise some of the most architecturally complex and functional-group-dense secondary metabolites isolated. Consequently, they present a substantial challenge for chemical synthesis. The synthesis approach described here is a notable departure from other single-target-focused strategies adopted for the syntheses of related structures. Specifically, it affords not only the targeted natural products, but also intermediates and derivatives in the three subfamilies of diterpenoid alkaloids (C-18, C-19 and C-20), and so provides a unified synthetic strategy for these natural products. This work validates the utility of network analysis as a starting point for identifying strategies for the syntheses of architecturally complex secondary metabolites.
Suggested Citation
C. J. Marth & G. M. Gallego & J. C. Lee & T. P. Lebold & S. Kulyk & K. G. M. Kou & J. Qin & R. Lilien & R. Sarpong, 2015.
"Network-analysis-guided synthesis of weisaconitine D and liljestrandinine,"
Nature, Nature, vol. 528(7583), pages 493-498, December.
Handle:
RePEc:nat:nature:v:528:y:2015:i:7583:d:10.1038_nature16440
DOI: 10.1038/nature16440
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Stefan Wiesler & Goh Sennari & Mihai V. Popescu & Kristen E. Gardner & Kazuhiro Aida & Robert S. Paton & Richmond Sarpong, 2024.
"Late-stage benzenoid-to-troponoid skeletal modification of the cephalotanes exemplified by the total synthesis of harringtonolide,"
Nature Communications, Nature, vol. 15(1), pages 1-8, December.
- Alina Bărbulescu & Lucica Barbeș & Cristian Ștefan Dumitriu, 2022.
"Computer-Aided Methods for Molecular Classification,"
Mathematics, MDPI, vol. 10(9), pages 1-19, May.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:528:y:2015:i:7583:d:10.1038_nature16440. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.